skip to Main Content
enquiries@thearmchairtrader.com

Sign up for our Free Daily Digest newsletter: Actionable insight every morning, designed for the self-directed investor. Find out more

Falling from their record highs by the end of last week, trading is still largely being dictated by the coronavirus.

US: Economic impact of the Coronavirus

There is perhaps the sense that the markets are caught between two stages of the coronavirus: the short-term, and ongoing, examination of new cases and death tolls, especially outside China; and the long-term, yet to fully emerge economic impact of the illness.

So far we’ve had revenue warnings from Apple and a host of other companies, alongside reports that the outbreak could cost the airline industry $30 billion. As for Friday’s much-anticipated flash manufacturing PMIs, they were broadly better than forecast. However, they also all arrived thick with caveats detailing the issues affecting global supply chains, the kind that could well manifest in March’s readings.

Often the market-reaction to these problems has been mitigated by reports of Chinese stimulus – increasingly it looks like Beijing wants to spend its way out of a potential crisis.

It is hard not to see the patterns that have defined trading throughout February repeating in the month’s final week. There’s been a tendency for investors to try and ignore bad news for as long as possible, building markets up to a variety of different – often all-time – highs, before tumbling on one bad headline too many. And then the process begins again.

In terms of US data, there’s the CB consumer confidence reading on Tuesday; the second look at fourth quarter GDP, alongside the latest durable goods orders, on Thursday; and the core PCE prince index and Chicago PMI figures on Friday.

Interesting the most important numbers of the week don’t arrive until the early hours of Saturday morning, as China posts its own manufacturing and services PMIs.

UK: Trade negotiations with the EU

The UK is almost entirely devoid of interesting data this week, leaving it at the mercy of macro-movements (mainly for the FTSE) and the ongoing slanging match between the UK and EU ahead of March’s trade negations (an issue mainly felt by the pound).

UK: Stocks to watch

There is, however, a pretty busy corporate calendar. Croda International and Hammerson report on Tuesday, followed by Rio Tinto and Taylor Wimpey on Wednesday. Thursday then sees only of those stupidly overstuffed sessions, including statements from Hikma Pharmaceuticals, Mondi, Persimmon, Provident Financial, Reckitt Benickser, Rentokil Initial, RSA Insurance and WPP.

Eurozone: Macroeconomic events set to dictate

Like in the UK and US, it is hard to see the Eurozone striking out on its own this week. As for its data, there’s the German Ifo business climate number on Monday, the Spanish inflation reading on Thursday and the French GDP and Eurozone-wide inflation readings on Friday.

This article is brought to you in association with Spreadex. All opinions expressed in this article are from the author and do not necessarily represent the opinions of The Armchair Trader. You can find out more about Spreadex products and services here, or find more articles from Connor Campbell here.

Please note this article does not constitute investment advice. Investors are encouraged to do their own research beforehand or consult a professional advisor.

Connor Campbell

Connor Campbell

Connor joined Spreadex in 2014 as part of a newly expanded financial analyst team after graduating from the University of Southampton with an MA in English. His focus is on providing Spreadex's customers with up-to-date and informative news, and is responsible for the market analysis found on the Spreadex website.

Connor produces three daily market updates, a daily stock earnings preview, a weekly financial market preview piece every Friday, a round-up of all the big financial stories making the weekend press every Monday morning and regular stock market features.

Comments

Back To Top